Arctic Bioscience AS (OSL:ABS) FCF Margin %: -35.21% (As of Dec. 2025)


OSL:ABS Arctic Bioscience AS OSL:ABS
55 GF Score
Price kr3.19
GF Value kr10.61
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Arctic Bioscience AS FCF Margin %?

Arctic Bioscience AS OSL:ABS -1.85% 55 FCF Margin % is -35.21% as of Dec. 2025. GuruFocus rates OSL:ABS with a GF Score™ of 55/100 and a GF Value™ of kr10.61 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 949 Biotechnology companies, Arctic Bioscience AS ranks worse than 54.06% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Arctic Bioscience AS's Free Cash Flow for the six months ended in Dec. 2025 was kr-8.05 Mil. Arctic Bioscience AS's Revenue for the six months ended in Dec. 2025 was kr22.87 Mil. Therefore, Arctic Bioscience AS's FCF Margin % for the quarter that ended in Dec. 2025 was -35.21%.

As of today, Arctic Bioscience AS's current FCF Yield % is -52.81%.

The historical rank and industry rank for Arctic Bioscience AS's FCF Margin % or its related term are showing as below:

OSL:ABS' s FCF Margin % Range Over the Past 10 Years
Min: -353.23   Med: -206.99   Max: -113.23
Current: -113.23

During the past 8 years, the highest FCF Margin % of Arctic Bioscience AS was -113.23%. The lowest was -353.23%. And the median was -206.99%.

OSL:ABS's FCF Margin % is ranked worse than
54.06% of 949 companies
in the Biotechnology industry
Industry Median: -82.65 vs OSL:ABS: -113.23

Arctic Bioscience AS FCF Margin % Related Terms

Arctic Bioscience AS FCF Margin % Historical Data

* Premium members only.

The historical data trend for Arctic Bioscience AS's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arctic Bioscience AS FCF Margin % Chart

Arctic Bioscience AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial -353.23 -244.98 -192.81 -221.16 -113.23

Arctic Bioscience AS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -93.69 -355.24 -137.19 -216.77 -35.21

OSL:ABS vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Arctic Bioscience AS's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arctic Bioscience AS FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arctic Bioscience AS's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Arctic Bioscience AS's FCF Margin % falls into.


OSL:ABS
55GF Score
Arctic Bioscience AS OSL:ABS
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arctic Bioscience AS FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Arctic Bioscience AS's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-45.4/40.096
=-113.23 %

Arctic Bioscience AS's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-8.05/22.866
=-35.21 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -35.21% mean?
Arctic Bioscience AS (OSL:ABS) has a FCF Margin % of -35.21% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Arctic Bioscience AS and its competitors. According to the industry distribution chart, Arctic Bioscience AS ranks #513 out of 949 companies in the Biotechnology industry, placing it in the top 54.1%.
Is Arctic Bioscience AS's FCF Margin % too high?
Arctic Bioscience AS's current FCF Margin % is -35.21%. Based on the distribution chart, Arctic Bioscience AS ranks #513 out of 949 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Arctic Bioscience AS has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arctic Bioscience AS's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Arctic Bioscience AS ranks #513 out of 949 companies for FCF Margin %. This places Arctic Bioscience AS in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Arctic Bioscience AS and its competitors. Arctic Bioscience AS's current FCF Margin % is -35.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arctic Bioscience AS stock overvalued right now?
Based on GuruFocus' analysis, Arctic Bioscience AS (OSL:ABS) is currently considered Possible Value Trap. The stock's GF Value™ is kr10.61, compared to a current price of kr3.19 — trading 69.9% below its estimated fair value. The current FCF Margin % is -35.21%. Arctic Bioscience AS's overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Arctic Bioscience AS (OSL:ABS), the current FCF Margin % is -35.21% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arctic Bioscience AS (OSL:ABS) Overvalued in 2026?

Based on GuruFocus' analysis, Arctic Bioscience AS stock appears to be undervalued. The current stock price of kr3.19 is trading 69.9% below its estimated GF Value™ of kr10.61. GuruFocus considers Arctic Bioscience AS to be Possible Value Trap.

Key valuation signals for OSL:ABS:

  • FCF Margin %: -35.21%
  • GF Value™: kr10.61 vs. price of kr3.19 (69.9% below fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the OSL:ABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arctic Bioscience AS Business Description

Other Exchanges 9TD:Germany
Address Industrivegen 42, Orsta, NOR, 6155
Arctic Bioscience AS is a clinical-stage biotechnology company working to develop drug candidates within the areas of autoimmune and inflammatory diseases. It is developing pharmaceutical and commercializing nutraceutical products based on bioactive marine compounds, including lipids essential to maintaining cell membranes. The company's proprietary extraction technology is used to extract membrane fats from marine raw materials, such as herring roe and algae. Geographically, the company operates in Norway, the Americas, Europe, and APAC, with the majority of the revenue derived from the Americas.
55GF Score

Get the complete analysis for OSL:ABS

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.19
Price
kr10.61
GF Value